Filing Flows › Celldex Therapeutics (CLDX) › Contracts and grants revenue
Celldex Therapeutics (CLDX) Contracts and grants revenue by quarter
Celldex Therapeutics' Contracts and grants revenue was $15K in Q2 2026 (second quarter 2026), -81% from Q4 2025. Over the last 5 quarters it ranged from $15K (Q2 2026) to $1.2M (Q4 2024).
| Quarter | Contracts and grants revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $15K | -81% | -98% |
| Q4 2025 | $81K | -89% | -93% |
| Q2 2025 | $723K | +12% | — |
| Q1 2025 | $645K | -45% | — |
| Q4 2024 | $1.2M | — | — |
Q2 2026 at a glance
Celldex Therapeutics, Q2 2026: revenue $22K (-97% year over year), net loss $73.5M, operating cash flow −$57.4M. The chart follows the revenue to costs, profit and cash.
Questions
What is Celldex Therapeutics' Contracts and grants revenue?
Celldex Therapeutics' Contracts and grants revenue was $15K in Q2 2026 (second quarter 2026), -81% from Q4 2025.
How has Celldex Therapeutics' Contracts and grants revenue changed?
Over the last 5 quarters it ranged from $15K (Q2 2026) to $1.2M (Q4 2024).